Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.
FEBS J. 2021 Apr;288(8):2697-2726. doi: 10.1111/febs.15829. Epub 2021 Apr 6.
Proteinase-activated receptors (PARs) are a four-member family of G protein-coupled receptors defined by their irreversible proteolytic mechanism of activation. PARs have emerged as important regulators of various physiological responses and are implicated in numerous pathological conditions. Importantly, PAR1 and PAR4 are critical regulators of platelet function, while PAR2 is well established as a driver of inflammatory responses. PAR-targeted drug development efforts are therefore of great interest. In this review, we provide an overview of recent advances in our understanding of molecular mechanisms underlying PAR activation, effector interaction, and signaling. We also provide an overview of the diverse proteolytic enzymes that are now established as PAR regulators and describe the ability of different enzymes to elicit biased signaling through PARs. Finally, we highlight recent advances in the development of PAR-targeted pharmacological agents and discuss recent structure-activity relationship studies.
蛋白酶激活受体(PARs)是一个由四个成员组成的 G 蛋白偶联受体家族,其激活机制为不可逆的蛋白水解。PARs 已成为各种生理反应的重要调节剂,并与许多病理状况有关。重要的是,PAR1 和 PAR4 是血小板功能的关键调节剂,而 PAR2 则被广泛认为是炎症反应的驱动因素。因此,PAR 靶向药物的开发具有重要意义。在这篇综述中,我们概述了近年来对 PAR 激活、效应子相互作用和信号转导的分子机制的理解方面的最新进展。我们还概述了现已确立的作为 PAR 调节剂的多种蛋白水解酶,并描述了不同酶通过 PAR 产生偏向信号的能力。最后,我们强调了 PAR 靶向药理学制剂的最新进展,并讨论了最近的结构-活性关系研究。